Solid Tumors

Print
PDF

10231 Phase 1/2 Study of PX-866 and docetaxel in patients with solid tumors (PX-866-002)

09115 (MEK113486): A Open-Label, Phase I/Ib Dose Escalation Study to Assess the Safety and Tolerability of GSK1120212 in Combination with Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, or nab-Paclitaxel in Subjects with Advanced Solid Tumors

09249 A Randomized, Blinded, Placebo-Controlled, Two-Phase, Sequential Cohort, Dose Finding Study to Assess the Safety and Efficacy of an Oral Thrombopoietin, Receptor Agonist, Eltrombopag (SB-497115-GR), Administered to Patients with Solid Tumors Receiving Gemcitabine Monotherapy or the combination of Gemcitabine Plus Carboplatin or Cisplatin Chemotherapy (TRC112765).

06146 A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous XMT-1001 in Patients with Advanced Solid Tumors (MER-001)

 

Please contact the NYOH Research Department for more information on clinical trials at (518) 489-0044 ext. 1239